Promising Drug Fondaparinux for the Treatment of COVID-19: an In Silico Analysis of Low Molecular Weight Heparin, Direct Oral Anticoagulant, and Antiplatelet Drug Interactions with Host Protease Furin

PURPOSE: As of July 2022, the COVID-19 pandemic has affected over 555 million worldwide confirmed cases and caused more than 6.3 million deaths. The studies showed that the D-dimer levels were increased in non-survivors compared to survivors and heparin treatment has begun to be administered to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ertan-Bolelli, Tugba, Bolelli, Kayhan, Elçi, Sıtkı Doga, Belen-Apak, F. Burcu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676724/
https://www.ncbi.nlm.nih.gov/pubmed/36401727
http://dx.doi.org/10.1007/s10557-022-07406-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676724/
https://www.ncbi.nlm.nih.gov/pubmed/36401727
http://dx.doi.org/10.1007/s10557-022-07406-z

Ejemplares similares